The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second-line treatment outcomes following first-line chemotherapy plus immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter study.
 
Elvire Pons-Tostivint
Consulting or Advisory Role - AstraZeneca; Sanofi Pasteur; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Sanofi; Takeda
 
Remy Ezzedine
No Relationships to Disclose
 
Thomas Goronflot
No Relationships to Disclose
 
Perrine Crequit
No Relationships to Disclose
 
Thierry Chatellier
No Relationships to Disclose
 
Judith Raimbourg
Honoraria - Amgen; BMS GmbH & Co. KG; Merck; Sanofi Pasteur; Servier
Travel, Accommodations, Expenses - Pierre Fabre
 
Jaafar Bennouna
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Daichii; Daichii; Ipsen; Janssen Oncology; MSD Oncology; Novartis; SERVIER
Consulting or Advisory Role - AMGEN; AstraZeneca; Bristol-Myers Squibb; MSD; Novartis; Roche; SERVIER
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Roche
 
Etienne Giroux Leprieur
No Relationships to Disclose
 
Marie Porte
No Relationships to Disclose